title: Optical neuropathy possibly related to arsenic during acute promyelocytic leukemia treatment.
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Thery
authors.forename: Fabrice
authors.initials: F
authors.lastname: Jardin
authors.forename: Nathalie
authors.initials: N
authors.lastname: Massy
authors.forename: Jerome
authors.initials: J
authors.lastname: Massy
authors.forename: Aspasia
authors.initials: A
authors.lastname: Stamatoullas
authors.forename: Hervé
authors.initials: H
authors.lastname: Tilly
mesh_terms: D000328:Adult; D001151:Arsenic / Q000009:adverse effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy*; D018917:Optic Neuropathy, Ischemic / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D010087:Oxides / Q000009:adverse effects
chemical_list: D001152:Arsenicals; D010087:Oxides; D001151:Arsenic; D000077237:Arsenic Trioxide